Us Bancorp \De\ Pacira Bio Sciences, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,733 shares of PCRX stock, worth $45,231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,733
Previous 1,967
11.9%
Holding current value
$45,231
Previous $29,000
10.34%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding PCRX
# of Institutions
251Shares Held
48.3MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$209 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$138 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$85.2 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$52.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$51.7 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.2B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...